| Return to Contents in this Issue |
Practitioner's Corner |
|
Omalizumab in Severe Allergic Asthma: Efficacy Assessment by Comparison of Symptom Score and Peak Expiratory Flow Values Before and After Therapy |
|
G Kourtis,1 AS Rucco,1 F Loconte,1 MF Caiaffa,2 L Macchia1 |
|
1Department of Allergology and
Clinical Immunology, University of Bari, Bari, Italy |
|
J Investig Allergol Clin Immunol 2010; Vol. 20(5): 446-453 |
|
|
